{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:48:29Z","timestamp":1792784909218,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":17,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Key Laboratory of Exercise and Health Sciences (Shanghai University of Sport) Ministry of Education","id":[{"id":"https:\/\/ror.org\/0056pyw12","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Shanghai Key Technology R&D Program: Medical Innovation Research Project","award":["25Y42800200"],"award-info":[{"award-number":["25Y42800200"]}]},{"name":"the National Natural Science Foundation of China","award":["32571337"],"award-info":[{"award-number":["32571337"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"DOI":"10.1038\/s41531-026-01519-0","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T17:55:21Z","timestamp":1788198921000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Coffee and Parkinson\u2019s disease: associations by CYP1A2 genotype and sex in UK Biobank"],"prefix":"10.1038","volume":"12","author":[{"given":"Jieping","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuyi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geng","family":"Zong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Zhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guodong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"1519_CR1","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1016\/S0140-6736(04)16305-8","volume":"363","author":"A Samii","year":"2004","unstructured":"Samii, A., Nutt, J. G. & Ransom, B. R. Parkinson\u2019s disease. Lancet 363, 1783\u20131793 (2004).","journal-title":"Lancet"},{"key":"1519_CR2","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.amjmed.2019.03.001","volume":"132","author":"MT Hayes","year":"2019","unstructured":"Hayes, M. T. Parkinson\u2019s disease and Parkinsonism. Am. J. Med. 132, 802\u2013807 (2019).","journal-title":"Am. J. Med."},{"key":"1519_CR3","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","volume":"17","author":"ER Dorsey","year":"2018","unstructured":"Dorsey, E. R. et al. Global, regional, and national burden of Parkinson\u2019s disease, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 17, 939\u2013953 (2018).","journal-title":"Lancet Neurol."},{"key":"1519_CR4","first-page":"2019","volume":"ume 10","author":"N Ball","year":"2019","unstructured":"Ball, N., Teo, W.-P., Chandra, S. & Chapman, J. Parkinson\u2019s disease and the environment. Mini Rev. Front. Neurol. ume 10, 2019 (2019).","journal-title":"Mini Rev. Front. Neurol."},{"key":"1519_CR5","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.neuro.2012.01.010","volume":"33","author":"WM Caudle","year":"2012","unstructured":"Caudle, W. M., Guillot, T. S., Lazo, C. R. & Miller, G. W. Industrial toxicants and Parkinson\u2019s disease. Neurotoxicology 33, 178\u2013188 (2012).","journal-title":"Neurotoxicology"},{"key":"1519_CR6","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1159\/000450855","volume":"47","author":"YH Chuang","year":"2016","unstructured":"Chuang, Y. H. et al. Gene-environment Interaction in Parkinson\u2019s disease: Coffee, ADORA2A, and CYP1A2. Neuroepidemiology 47, 192\u2013200 (2016).","journal-title":"Neuroepidemiology"},{"key":"1519_CR7","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3233\/JPD-191683","volume":"9","author":"S Cerri","year":"2019","unstructured":"Cerri, S., Mus, L. & Blandini, F. Parkinson\u2019s disease in women and men: what\u2019s the difference? J. Parkinsons Dis. 9, 501\u2013515 (2019).","journal-title":"J. Parkinsons Dis."},{"key":"1519_CR8","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1212\/WNL.0000000000004764","volume":"90","author":"N Dahodwala","year":"2018","unstructured":"Dahodwala, N. et al. Sex disparities in access to caregiving in Parkinson disease. Neurology 90, e48\u2013e54 (2018).","journal-title":"Neurology"},{"key":"1519_CR9","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1210\/er.2016-1007","volume":"37","author":"A Villa","year":"2016","unstructured":"Villa, A., Vegeto, E., Poletti, A. & Maggi, A. Estrogens, neuroinflammation, and neurodegeneration. Endocr. Rev. 37, 372\u2013402 (2016).","journal-title":"Endocr. Rev."},{"key":"1519_CR10","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.3390\/nu12061860","volume":"12","author":"CT Hong","year":"2020","unstructured":"Hong, C. T., Chan, L. & Bai, C.-H. The effect of caffeine on the risk and progression of Parkinson\u2019s disease: a meta-analysis. Nutrients 12, 1860 (2020).","journal-title":"Nutrients"},{"key":"1519_CR11","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209201","volume":"102","author":"Y Zhao","year":"2024","unstructured":"Zhao, Y. et al. Association of coffee consumption and prediagnostic caffeine metabolites with incident Parkinson disease in a population-based cohort. Neurology 102, e209201 (2024).","journal-title":"Neurology"},{"key":"1519_CR12","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1016\/j.parkreldis.2020.10.024","volume":"80","author":"J-F Chen","year":"2020","unstructured":"Chen, J.-F. & Schwarzschild, M. A. Do caffeine and more selective adenosine A2A receptor antagonists protect against dopaminergic neurodegeneration in Parkinson\u2019s disease? Parkinson. Relat. Disord. 80, S45\u2013S53 (2020).","journal-title":"Parkinson. Relat. Disord."},{"key":"1519_CR13","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/cns.12684","volume":"23","author":"M Kolahdouzan","year":"2017","unstructured":"Kolahdouzan, M. & Hamadeh, M. J. The neuroprotective effects of caffeine in neurodegenerative diseases. CNS Neurosci. Ther. 23, 272\u2013290 (2017).","journal-title":"CNS Neurosci. Ther."},{"key":"1519_CR14","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3389\/fnins.2018.00301","volume":"12","author":"Y Luan","year":"2018","unstructured":"Luan, Y. et al. Chronic caffeine treatment protects against \u03b1-synucleinopathy by reestablishing autophagy activity in the mouse striatum. Front. Neurosci. 12, 301 (2018).","journal-title":"Front. Neurosci."},{"key":"1519_CR15","first-page":"2020","volume":"ume 14","author":"X Ren","year":"2020","unstructured":"Ren, X. & Chen, J.-F. Caffeine and Parkinson\u2019s disease: multiple benefits and emerging mechanisms. Rev. Front. Neurosci. ume 14, 2020 (2020).","journal-title":"Rev. Front. Neurosci."},{"key":"1519_CR16","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1124\/pr.117.014407","volume":"70","author":"A Nehlig","year":"2018","unstructured":"Nehlig, A. Interindividual differences in caffeine metabolism and factors driving caffeine consumption. Pharmacol. Rev. 70, 384\u2013411 (2018).","journal-title":"Pharmacol. Rev."},{"key":"1519_CR17","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00394-020-02427-6","volume":"60","author":"J Grgic","year":"2021","unstructured":"Grgic, J., Pickering, C., Del Coso, J., Schoenfeld, B. J. & Mikulic, P. CYP1A2 genotype and acute ergogenic effects of caffeine intake on exercise performance: A systematic review. Eur. J. Nutr. 60, 1181\u20131195 (2021).","journal-title":"Eur. J. Nutr."},{"key":"1519_CR18","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.jshs.2023.12.005","volume":"13","author":"J Wang","year":"2024","unstructured":"Wang, J. et al. Does ergogenic effect of caffeine supplementation depend on CYP1A2 genotypes? A systematic review with meta-analysis. J. Sport Health Sci. 13, 499\u2013508 (2024).","journal-title":"J. Sport Health Sci."},{"key":"1519_CR19","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/s41397-017-0011-3","volume":"18","author":"N Koonrungsesomboon","year":"2018","unstructured":"Koonrungsesomboon, N., Khatsri, R., Wongchompoo, P. & Teekachunhatean, S. The impact of genetic polymorphisms on CYP1A2 activity in humans: a systematic review and meta-analysis. Pharmacogenom. J. 18, 760\u2013768 (2018).","journal-title":"Pharmacogenom. J."},{"key":"1519_CR20","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1111\/j.1468-1331.2011.03353.x","volume":"18","author":"R Popat","year":"2011","unstructured":"Popat, R. et al. Coffee, ADORA2A, and CYP1A2: the caffeine connection in Parkinson\u2019s disease. Eur. J. Neurol. 18, 756\u2013765 (2011).","journal-title":"Eur. J. Neurol."},{"key":"1519_CR21","doi-asserted-by":"publisher","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow, C. et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 12, e1001779 (2015).","journal-title":"PLoS Med."},{"key":"1519_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102381","volume":"99","author":"Y Yang","year":"2024","unstructured":"Yang, Y., Zhou, Z. D., Yi, L., Tan, B. J. & Tan, E. K. Interaction between caffeine consumption & genetic susceptibility in Parkinson\u2019s disease: A systematic review. Ageing Res. Rev. 99, 102381 (2024).","journal-title":"Ageing Res. Rev."},{"key":"1519_CR23","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1001\/jamainternmed.2018.2425","volume":"178","author":"E Loftfield","year":"2018","unstructured":"Loftfield, E. et al. Association of coffee drinking with mortality by genetic variation in caffeine metabolism: findings from the UK Biobank. JAMA Intern. Med. 178, 1086\u20131097 (2018).","journal-title":"JAMA Intern. Med."},{"key":"1519_CR24","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1212\/01.WNL.0000046523.05125.87","volume":"60","author":"A Ascherio","year":"2003","unstructured":"Ascherio, A. et al. Caffeine, postmenopausal estrogen, and risk of Parkinson\u2019s disease. Neurology 60, 790\u2013795 (2003).","journal-title":"Neurology"},{"key":"1519_CR25","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.parkreldis.2010.02.012","volume":"16","author":"N Palacios","year":"2010","unstructured":"Palacios, N. et al. Polymorphisms of caffeine metabolism and estrogen receptor genes and risk of Parkinson\u2019s disease in men and women. Parkinson. Relat. Disord. 16, 370\u2013375 (2010).","journal-title":"Parkinson. Relat. Disord."},{"key":"1519_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.752826","volume":"12","author":"J Grzegorzewski","year":"2021","unstructured":"Grzegorzewski, J., Bartsch, F., K\u00f6ller, A. & K\u00f6nig, M. Pharmacokinetics of caffeine: a systematic analysis of reported data for application in metabolic phenotyping and liver function testing. Front Pharm. 12, 752826 (2021).","journal-title":"Front Pharm."},{"key":"1519_CR27","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1523\/JNEUROSCI.3008-05.2006","volume":"26","author":"K Xu","year":"2006","unstructured":"Xu, K. et al. Estrogen prevents neuroprotection by caffeine in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson\u2019s disease. J. Neurosci. 26, 535\u2013541 (2006).","journal-title":"J. Neurosci."},{"key":"1519_CR28","first-page":"5472","volume":"25","author":"MC Cornelis","year":"2016","unstructured":"Cornelis, M. C. et al. Genome-wide association study of caffeine metabolites provides new insights to caffeine metabolism and dietary caffeine-consumption behavior. Hum. Mol. Genet. 25, 5472\u20135482 (2016).","journal-title":"Hum. Mol. Genet."},{"key":"1519_CR29","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/mp.2014.107","volume":"20","author":"MC Cornelis","year":"2015","unstructured":"Cornelis, M. C. et al. Genome-wide meta-analysis identifies six novel loci associated with habitual coffee consumption. Mol. Psychiatry 20, 647\u2013656 (2015).","journal-title":"Mol. Psychiatry"},{"key":"1519_CR30","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1016\/S0140-6736(07)60924-6","volume":"369","author":"LJ Palmer","year":"2007","unstructured":"Palmer, L. J. UK Biobank: bank on it. Lancet 369, 1980\u20131982 (2007).","journal-title":"Lancet"},{"key":"1519_CR31","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41569-022-00719-4","volume":"19","author":"RM van Dam","year":"2022","unstructured":"van Dam, R. M. & Hu, F. B. Caffeine consumption and cardiovascular health. Nat. Rev. Cardiol. 19, 429\u2013430 (2022).","journal-title":"Nat. Rev. Cardiol."},{"key":"1519_CR32","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1046\/j.1365-2125.1999.00898.x","volume":"47","author":"C Sachse","year":"1999","unstructured":"Sachse, C., Brockm\u00f6ller, J., Bauer, S. & Roots, I. Functional significance of a C->A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine. Br. J. Clin. Pharmacol. 47, 445\u2013449 (1999).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"1519_CR33","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.toxlet.2004.12.005","volume":"156","author":"F Castorena-Torres","year":"2005","unstructured":"Castorena-Torres, F. et al. CYP1A2 phenotype and genotype in a population from the Carboniferous Region of Coahuila, Mexico. Toxicol. Lett. 156, 331\u2013339 (2005).","journal-title":"Toxicol. Lett."},{"key":"1519_CR34","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/add.13975","volume":"113","author":"AE Taylor","year":"2018","unstructured":"Taylor, A. E., Davey Smith, G. & Munaf\u00f2, M. R. Associations of coffee genetic risk scores with consumption of coffee, tea and other beverages in the UK Biobank. Addiction 113, 148\u2013157 (2018).","journal-title":"Addiction"}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01519-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01519-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01519-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:40:26Z","timestamp":1789627226000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01519-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1519"],"URL":"https:\/\/doi.org\/10.1038\/s41531-026-01519-0","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]},"assertion":[{"value":"7 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"226"}}